Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Sun Biopharma Inc (SNBP)

Sun Biopharma Inc (SNBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Panbela Therapeutics, Inc. Completes Enrollment in its Phase 1b Trial Investigating SBP-101 Combination Therapy for First Line Metastatic Pancreatic Cancer Globe NewsWire - Tue Dec 8, 2020

· Phase 1b Data Expected 1H 2021

SNBP : 3.45 (+0.29%)
PBLA : 0.4500 (+5.88%)
Sun BioPharma, Inc. Changes Name to Panbela Therapeutics Inc. Globe NewsWire - Tue Dec 1, 2020

MINNEAPOLIS, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer,...

SNBP : 3.45 (+0.29%)
Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results Globe NewsWire - Thu Nov 12, 2020

MINNEAPOLIS, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic...

SNBP : 3.45 (+0.29%)
Sun BioPharma, Inc. to Participate in the 11th Annual Craig-Hallum Alpha Select Conference Globe NewsWire - Tue Nov 10, 2020

MINNEAPOLIS, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic...

SNBP : 3.45 (+0.29%)
Sun BioPharma, Inc. Schedules Conference Call on November 12, 2020 to Report 2020 Third Quarter Financial Results Globe NewsWire - Mon Nov 2, 2020

MINNEAPOLIS, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic...

SNBP : 3.45 (+0.29%)
Sun BioPharma, Inc. Closes $10.5 Million Public Offering of Common Stock and Warrants Globe NewsWire - Tue Sep 1, 2020

MINNEAPOLIS, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic...

SNBP : 3.45 (+0.29%)
Sun BioPharma, Inc. Announces Pricing of $10.5 Million Public Offering and Uplisting to the Nasdaq Capital Market Globe NewsWire - Fri Aug 28, 2020

MINNEAPOLIS, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB:SNBP Nasdaq:SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients...

SNBP : 3.45 (+0.29%)
Sun BioPharma, Inc. Provides Business Update and Reports Q2 2020 Financial Results Globe NewsWire - Tue Aug 11, 2020

MINNEAPOLIS, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic...

SNBP : 3.45 (+0.29%)
Sun BioPharma, Inc. Appoints Jennifer K. Simpson, Ph.D., as President and CEO Globe NewsWire - Thu Jul 16, 2020

· Company founder Michael T. Cullen, M.D. will continue to serve as Executive Chairman

SNBP : 3.45 (+0.29%)
Sun BioPharma, Inc. Receives FDA Fast Track Designation for SBP-101 Globe NewsWire - Tue Jun 30, 2020

MINNEAPOLIS, June 30, 2020 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic...

SNBP : 3.45 (+0.29%)

Barchart Exclusives

Should You Follow Insider Buying On This High-Yield REIT? Barchart - Wed May 22, 6:30PM CDT
A director at Public Storage recently made a hefty investment in the company's stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot